The American Journal of Managed Care1 个月
Collaboration to Transition Members to Preferred Formulary Dipeptidyl-Peptidase-4 Inhibitor
DPP-4 inhibitors (alogliptin [Nesina, Vipidia], linagliptin [Tradjenta], saxagliptin [Onglyza], and sitagliptin [Januvia]) are a commonly used class of oral diabetes medications, particularly in ...